skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 454,253  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease
Material Type:
Article
Add to My Research

S789 Effect of Mirikizumab on Inflammatory Biomarkers in a Phase 2 Study of Patients With Crohn’s Disease

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S367-S367 [Peer Reviewed Journal]

2021 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000776688.39678.45

Full text available

2
BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING
Material Type:
Article
Add to My Research

BIOM-64. TARGETING IDENTIFICATION OF HOST-BRAIN CANCER SYSTEMIC CYTOKINE SIGNALLING FOR EARLY DETECTION AND TUMOUR SUB-TYPING

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii19-vii19 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.074

Full text available

3
BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION
Material Type:
Article
Add to My Research

BIOM-09. GUIDING PRECISION THERAPEUTICS THROUGH INTERROGATING ONCOGENIC PATHWAY ACTIVATION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii6 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.019

Full text available

4
BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER
Material Type:
Article
Add to My Research

BIOM-11. ROR1 MRNA EXPRESSION IN GLIOMA - A NOVEL PROGNOSTIC BIOMARKER

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii6-vii6 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.021

Full text available

5
BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS
Material Type:
Article
Add to My Research

BIOM-06. IDENTIFICATION OF AN INFLAMMATORY BIOMARKER SIGNATURE IN PLASMA-DERIVED EXTRACELLULAR VESICLES OF GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii5 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.016

Full text available

6
BIOM-30. ANALYSIS OF GLIOMA-RELATED GENES USING A BREAKTHROUGH AMPLIFICATION TECHNIQUE FOR CELL-FREE DNA IN CEREBROSPINAL FLUID
Material Type:
Article
Add to My Research

BIOM-30. ANALYSIS OF GLIOMA-RELATED GENES USING A BREAKTHROUGH AMPLIFICATION TECHNIQUE FOR CELL-FREE DNA IN CEREBROSPINAL FLUID

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii10-vii11 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.040

Full text available

7
BIOM-17. SPYING ON GLIOMAS: LONGITUDINAL CSF AS A PLATFORM FOR GLIOMA MONITORING AND RESPONSE BIOMARKER DISCOVERY
Material Type:
Article
Add to My Research

BIOM-17. SPYING ON GLIOMAS: LONGITUDINAL CSF AS A PLATFORM FOR GLIOMA MONITORING AND RESPONSE BIOMARKER DISCOVERY

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii7 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.027

Full text available

8
BIOM-50. THE IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF CIRCULAR RNA CIRC_63706 IN SONIC HEDGEHOG MEDULLOBLASTOMAS
Material Type:
Article
Add to My Research

BIOM-50. THE IDENTIFICATION AND FUNCTIONAL CHARACTERIZATION OF CIRCULAR RNA CIRC_63706 IN SONIC HEDGEHOG MEDULLOBLASTOMAS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii16 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.060

Full text available

9
BIOM-18. CLINICOGENOMIC PREDICTORS FOR THE PATTERN OF FAILURE IN HIGH-GRADE GLIOMA
Material Type:
Article
Add to My Research

BIOM-18. CLINICOGENOMIC PREDICTORS FOR THE PATTERN OF FAILURE IN HIGH-GRADE GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii7-vii8 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.028

Full text available

10
BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM “HEAD START” 4 PROTOCOL
Material Type:
Article
Add to My Research

BIOM-49. A PILOT STUDY OF CEREBROSPINAL FLUID EXOSOMAL SMALL RNA-SEQUENCING IN PEDIATRIC MEDULLOBLASTOMA PATIENTS ON THE NEXT CONSORTIUM “HEAD START” 4 PROTOCOL

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii16 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.059

Full text available

11
BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM
Material Type:
Article
Add to My Research

BIOM-47. PREDICTORS OF SEIZURE AT ONSET USING A FUNCTIONAL VARIANT ANALYSIS OF TARGETED NEXT GENERATION SEQUENCING IN GBM

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.057

Full text available

12
BIOM-58. ROLE OF CD79B Y196 MUTATION IN PCNSL AS A POTENT PREDICTIVE MARKER FOR FAVORABLE RESPONSE TO R-MPV TREATMENT AND DEVELOPMENT OF RAPID ALL-IN-ONE GENOTYPING SYSTEM FOR MOLECULAR MARKERS OF PCNSL
Material Type:
Article
Add to My Research

BIOM-58. ROLE OF CD79B Y196 MUTATION IN PCNSL AS A POTENT PREDICTIVE MARKER FOR FAVORABLE RESPONSE TO R-MPV TREATMENT AND DEVELOPMENT OF RAPID ALL-IN-ONE GENOTYPING SYSTEM FOR MOLECULAR MARKERS OF PCNSL

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii18-vii18 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.068

Full text available

13
BIOM-08. IL13RA2 AS A LIQUID BIOPSY BIOMARKER FOR NERVOUS SYSTEM TUMORS
Material Type:
Article
Add to My Research

BIOM-08. IL13RA2 AS A LIQUID BIOPSY BIOMARKER FOR NERVOUS SYSTEM TUMORS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii5-vii5 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.018

Full text available

14
BIOM-41. IDENTIFICATION OF GLIOMA CELLS BY PROFILING SINGLE-CELL BIOPHYSICAL PROPERTIES THROUGH MULTICONSTRICTION MICROFLUIDIC CHANNELS
Material Type:
Article
Add to My Research

BIOM-41. IDENTIFICATION OF GLIOMA CELLS BY PROFILING SINGLE-CELL BIOPHYSICAL PROPERTIES THROUGH MULTICONSTRICTION MICROFLUIDIC CHANNELS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii13-vii13 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.051

Full text available

15
BIOM-38. TETRASPANIN 12 AS A TUMOR SUPPRESSOR AND BIOMARKER PREDICTING GOOD PROGNOSIS OF MALIGNANT GLIOMA
Material Type:
Article
Add to My Research

BIOM-38. TETRASPANIN 12 AS A TUMOR SUPPRESSOR AND BIOMARKER PREDICTING GOOD PROGNOSIS OF MALIGNANT GLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii13 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.048

Full text available

16
BIOM-48. HOXD12 IS AN INDEPENDENTLY PROGNOSTIC AGE-ASSOCIATED INDICATOR FOR POOR SURVIVAL IN OLIGODENDROGLIOMA
Material Type:
Article
Add to My Research

BIOM-48. HOXD12 IS AN INDEPENDENTLY PROGNOSTIC AGE-ASSOCIATED INDICATOR FOR POOR SURVIVAL IN OLIGODENDROGLIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii15-vii15 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.058

Full text available

17
BIOM-32. DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS
Material Type:
Article
Add to My Research

BIOM-32. DNA METHYLATION SUBCLASSES PREDICT THE BENEFIT FROM GROSS TOTAL TUMOR RESECTION IN IDH-WILDTYPE GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii11-vii11 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.042

Full text available

18
BIOM-53. SPECIFIC MICRORNA EXPRESSION PATTERN PREDICTS RECURRENCE IN ATYPICAL MENINGIOMA
Material Type:
Article
Add to My Research

BIOM-53. SPECIFIC MICRORNA EXPRESSION PATTERN PREDICTS RECURRENCE IN ATYPICAL MENINGIOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii16-vii17 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.063

Full text available

19
BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)
Material Type:
Article
Add to My Research

BIOM-24. TARGETED NEXT-GENERATION SEQUENCING (NGS) OF TEMPORALLY MATCHED CEREBROSPINAL FLUID (CSF) AND TUMOR TISSUE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii9-vii9 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.034

Full text available

20
BIOM-37. EVALUATION OF TEMPORALIS MUSCLE THICKNESS WITH TOXICITY AND SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION
Material Type:
Article
Add to My Research

BIOM-37. EVALUATION OF TEMPORALIS MUSCLE THICKNESS WITH TOXICITY AND SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii12-vii12 [Peer Reviewed Journal]

The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2022 ;ISSN: 1522-8517 ;EISSN: 1523-5866 ;DOI: 10.1093/neuonc/noac209.047

Full text available

Results 1 - 20 of 454,253  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (412,003)

Refine My Results

Creation Date 

From To
  1. Before 1964  (25)
  2. 1964 To 1982  (39)
  3. 1983 To 1995  (11,035)
  4. 1996 To 2009  (82,616)
  5. After 2009  (360,408)
  6. More options open sub menu

Subject 

  1. Science & Technology  (385,784)
  2. Life Sciences & Biomedicine  (350,966)
  3. Humans  (290,855)
  4. Biomarkers  (228,605)
  5. Female  (173,231)
  6. Male  (157,221)
  7. Middle Aged  (117,958)
  8. Adult  (95,782)
  9. Aged  (90,524)
  10. Oncology  (76,556)
  11. Biomarkers - Blood  (72,153)
  12. Prognosis  (70,211)
  13. Animals  (64,597)
  14. Biological And Medical Sciences  (56,849)
  15. Tumors  (51,464)
  16. Proteins  (49,775)
  17. Patients  (49,227)
  18. Medical Sciences  (48,910)
  19. Gene Expression  (46,539)
  20. Risk Factors  (44,994)
  21. More options open sub menu

Language 

  1. English  (447,925)
  2. Japanese  (62,131)
  3. Portuguese  (3,136)
  4. Spanish  (1,782)
  5. German  (1,702)
  6. French  (1,219)
  7. Chinese  (820)
  8. Russian  (648)
  9. Norwegian  (634)
  10. Polish  (470)
  11. Korean  (356)
  12. Italian  (262)
  13. Turkish  (252)
  14. Swedish  (205)
  15. Czech  (92)
  16. Serbian  (76)
  17. Dutch  (76)
  18. Persian  (72)
  19. Ukrainian  (66)
  20. Croatian  (61)
  21. More options open sub menu

Searching Remote Databases, Please Wait